Sanofi has completed its acquisition of Blueprint Medicines, enhancing its portfolio with a commercialised therapy and the ...

Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical ...

The transaction between Thermo Fisher and Sanofi is scheduled for completion in Q2 2025, subject to standard closing ...

Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...

Thermo Fisher is acquiring Sanofi’s Ridgefield, NJ sterile drug plant, transferring 200 employees to bolster U.S. fill‑finish ...

Q2 2025 Earnings Call Transcript July 23, 2025 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is ...

Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.

Q2 2025 Management View CEO Marc N. Casper highlighted "excellent operational performance in the quarter, reflecting active management of our company and the strength of our proven growth strategy and ...

Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.

Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...

Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing ...

The investment is highlighted by a state-of-the-art API facility in Virginia and expansions across multiple states.